4.4 Article

Risk of Recurrence and Survival After Relapse in Patients With Ewing Sarcoma

Related references

Note: Only part of the references are listed.
Review Oncology

Approaching Ewing sarcoma

Uta Dirksen et al.

FUTURE ONCOLOGY (2010)

Article Oncology

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

Ruth Ladenstein et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Pediatrics

Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors

David Barrett et al.

PEDIATRIC CLINICS OF NORTH AMERICA (2010)

Letter Oncology

Low Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma

Nicolas Andre et al.

PEDIATRIC BLOOD & CANCER (2009)

Article Oncology

Irinotecan and Temozolomide for Ewing Sarcoma: The Memorial Sloan-Kettering Experience

Denise A. Casey et al.

PEDIATRIC BLOOD & CANCER (2009)

Review Oncology

Ewing sarcoma: prognostic criteria, outcomes and future treatment

Patrick J. Leavey et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2008)

Article Oncology

Survival after recurrence of Ewing's sarcoma family of tumors

LM Barker et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Oncology

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma

AG Shankar et al.

MEDICAL AND PEDIATRIC ONCOLOGY (2003)

Article Oncology

Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

A Schuck et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)